Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1140220210260020118
´ëÇѾϿ¹¹æÇÐȸÁö
2021 Volume.26 No. 2 p.118 ~ p.127
Protective Effects of Silibinin on Helicobacter pylori-induced Gastritis: NF-¥êB and STAT3 as Potential Targets
Cho Kyung-Hwa

Lee Hee-Geum
Piao Juan-Yu
Kim Su-Jung
Na Hye-Kyung
Surh Young-Joon
Abstract
More than half of the world¡¯s populations are considered to be infected by Helicobacter pylori. It causes a chronic inflammation of the stomach, which is implicated in the pathogenesis of gastric ulcer and cancer. Silibinin, a polyphenolic flavonoid derived from milk thistle, has been known for its hepatoprotective effects, and recent studies have revealed its chemopreventive potential. In the present study, we examined the anti-inflammatory effects of silibinin in human gastric cancer MKN-1 cells and in the stomach of C57BL/6 mice infected by H. pylori. Pretreatment with silibinin attenuated the up-regulation of COX-2 and inducible nitric oxide synthase (iNOS) in H. pylori-infected MKN-1 cells and mouse stomach. In addition, the elevated translocation and DNA binding of NF- ¥êB and STAT3 induced by H. pylori infection were inhibited by silibinin treatment. Moreover, H. pylori infection in combination with high salt diet resulted in dysplasia and hyperplasia in mouse stomach, and these pathological manifestations were substantially mitigated by silibinin administration. Taken together, these findings suggest that silibinin exerts anti-inflammatory effects against H. pylori infection through suppression of NF-¥êB and STAT3 and subsequently, expression of COX-2 and iNOS.
KEYWORD
Helicobacter pylori, Silibinin, NF-¥êB, STAT3, Gastritis
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed